Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Pulsed electric field treatment may help shrink untreated liver tumors.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Reporter characteristics affect detection of hair loss from cancer therapy.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

GnRH treatment can reduce breast cancer cell invasion.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

ZD1839 can cause skin issues like acne and hair changes.

Erlotinib can cause hair loss as a side effect.

Gefitinib can cause hair and eyebrow darkening.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.